Effect of hyperbaric oxygen on venous PO2, transcutaneous PO2, and VO2max in a normobaric environment

Purpose. The purpose was to examine venous PO2, transcutaneous tissue PO2 (PtcO 2), and VO2max in a normobaric environment following a single HBO2 treatment. Methods. Ten moderately trained (VO2max = 57.6 mL·kg-1·min -1) males volunteered for the study. Baseline testing include...

Full description

Bibliographic Details
Main Author: Hodges, Alastair N. H.
Other Authors: Montgomery, David (advisor)
Format: Others
Language:en
Published: McGill University 2000
Subjects:
Online Access:http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=30175
Description
Summary:Purpose. The purpose was to examine venous PO2, transcutaneous tissue PO2 (PtcO 2), and VO2max in a normobaric environment following a single HBO2 treatment. Methods. Ten moderately trained (VO2max = 57.6 mL&middot;kg-1&middot;min -1) males volunteered for the study. Baseline testing included measures of VO2max, PtcO2, and anthropometry. Subjects received two HBO2 treatments, which consisted of breathing 95% oxygen at 2.5 ATA for 90 min. Following the first HBO2 treatment (6.0 +/- 1.0 min), subjects performed a VO2max test. Following the second HBO2 treatment, leg and chest PtcO2 and venous PO2 were monitored for 60 min. Results . VO2max, running time, and peak La were not altered (p < 0.05) post-HBO2 treatment. Leg PtcO2 was lower (p < 0.05) and chest PtcO2 was unchanged following the HBO2 treatment compared to baseline values. Venous PO2 was lower in the first 3 min post-HBO2 treatment than subsequent values, but no other differences were found (p < 0.05). Conclusion. The results of this study show that a single HBO 2 treatment at 2.5 ATA for 90 min does not elevate venous PO2, PtcO2, or VO2max in a normobaric, normoxic environment.